Phorm Corp

Phorm Corp (PHRM)

Company name:Phorm Corp
Company Description:A group engaged in behavioural and contextual online advertising
EPIC:PHRM (delisted)Trading Currency:GBX
Market Sector:AIMTISIN:SG9999009278
Market Segment:AIMIShare Type:DE
WWW Address: NPV (DI)
Industry Sector:MEDIA
 Price Price Change [%] Bid Offer Open High Low Volume
 1.00 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 9.82 981.68 -0.00 -6.27 - - - -

Phorm Key Figures

(at previous day's close)
Market Cap.9.82m
Shares In Issue981.68m
Prev. Close1.00
PE Ratio- 
Dividend Yield-%
EPS - basic-6.27p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-2.63p
Return On Equity (ROE)-%
Operating Margin-11,533.10%
PEG Factor- 
EPS Growth Rate50.00%
Dividends PS Growth Rate-%
Net Debt6.43m
Gross Gearing341.64%
Quick Assets1.55m
Net Working Capital-5.24m
Intangibles / Fixed Assets-%
Turnover PS0.02p
Pre-Tax Profit PS-2.65p
Retained Profit PS-3.13p
Cash PS0.04p
Net Cash PS-0.66p
Net Tangible Asset Value PS *-0.49p
Net Asset Value PS-0.49p
Spread- (-%) 

Phorm Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Phorm Historic Returns

Sorry No Data Available

Phorm Key Management Ratios

Phorm Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.97 
Tobin's Q Ratio (excl. intangibles)0.97 
Dividend Yield-%
Market-to-Book Ratio-2.04 
Price-to-Pre-Tax Profit PS-0.38 
Price-to-Retained Profit PS-0.32 
Price-to-Cash Flow PS-0.38 
Price-to-Sales PS43.56 
Price-to-Net Tangible Asset Value PS-2.04 
Price-to-Cash PS27.20 
Net Working Capital PS-0.53 
Price Pct to Working Capital PS-1.87%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Phorm Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing323.49%
Net Gearing (excl. Intangibles)323.49%
Gross Gearing341.64%
Gross Gearing (excl. Intangibles)341.64%
Gearing Under 1 Year341.64%
Gearing Under 1 Year (excl. Intgbl)341.64%
(Liquidity Ratios)
Net Working Capital to Total Assets-263.52%
Current Ratio0.23 
Quick Ratio (Acid Test)0.23 
Liquidity Ratio0.05 
Cash & Equiv/Current Assets23.23%
(Solvency Ratios)
Enterprise Value9.46m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.69 
Total Debt/Sales30.15 
Total Debt/Pre-Tax Profit-0.26 
Total Debt6.79m
Total Debt/Net Current Assets-1.30%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-52.36%
5 yr Compound Earnings Growth-45.14%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)
-0.0005Sorry No Data Available

Phorm Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)-305.16%
Net Profit Margin-13,644.62%
Assets Turnover0.02 
Return On Equity (ROE)-%
Return On Investment (ROI)-1,402.51%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-13,644.62%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.47 
Fixed Assets Turnover0.24 
Current Assets Turnover0.02 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales44.71 
Debt Collection Period6,510.01Days

Phorm Dividends

Sorry No Data Available

Phorm Fundamentals

 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
pre tax profit-62.54--58.08--46.60--40.49-m
attributable profit-62.54--58.08--46.60--47.90-m
retained profit-62.54--58.08--46.60--47.90-m
eps - basic-236.00 -74.00 -16.00 -8.00 
eps - diluted-236.00 -74.00 -16.00 -8.00 
dividends per share- - - - 

Phorm Balance Sheet

 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
 31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
fixed assets fixed assets1.065.34%0.768.46%1.217.10%0.6821.88%m
intangibles intangibles--%--%--%--%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors2.7313.67%2.3826.41%6.1836.24%1.8659.97%m
cash & securities cash & securities16.1580.99%5.8865.13%9.6656.66%0.5618.15%m
creditors - short creditors - short1.728.63%2.6529.41%5.1930.40%10.58341.64%m
creditors - long creditors - long--%--%3.4320.09%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves18.2291.37%6.3770.59%8.4449.51%-7.48-241.64%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Phorm Cash Flow Statement

31 Dec 2011 (USD)31 Dec 2012 (USD)31 Dec 2013 (USD)31 Dec 2014 (USD)
Operating CF-24.29-30.64-33.11-40.19m
Pre-Financing CF-25.43-31.10-34.70-40.91m
Retained CF11.09-10.493.64-9.29m

Phorm Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Phorm Corp
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200926 06:47:38